Zevra Therapeutics, Inc. Q4 2025 Earnings Preview

* Zevra Therapeutics, Inc. (ZVRA [https://seekingalpha.com/symbol/ZVRA]) is scheduled to announce Q4 earnings results on Monday, March 9th, after market close.
* The consensus EPS Estimate is $0.05 [https://seekingalpha.com/symbol/ZVRA/earnings/estimates] and the consensus Revenue Estimate is $28.05M (+133.8% Y/Y).
* Over the last 1 year, ZVRA has beaten EPS estimates [https://seekingalpha.com/symbol/ZVRA/earnings/eps-surprise-summary] 0% of the time and has beaten revenue estimates 50% of the time.

MORE ON ZEVRA THERAPEUTICS, INC.

* Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript [https://seekingalpha.com/article/4860276-zevra-therapeutics-inc-zvra-presents-at-44th-annual-j-p-morgan-healthcare-conference]
* Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow [https://seekingalpha.com/article/4860248-zevra-therapeutics-inc-zvra-presents-at-44th-annual-j-p-morgan-healthcare-conference]
* Zevra Therapeutics: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market [https://seekingalpha.com/article/4856967-zevra-therapeutics-stock-asymmetric-risk-reward-setup-in-ultra-rare-disease-market]
* Zevra Therapeutics appoints Justin Renz as CFO [https://seekingalpha.com/news/4561241-zevra-therapeutics-appoints-justin-renz-as-cfo]
* Seeking Alpha’s Quant Rating on Zevra Therapeutics, Inc. [https://seekingalpha.com/symbol/ZVRA/ratings/quant-ratings]